PROVIDER PROFILE · NPI 1457305260

Eduardo Trejo Derivet

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

42,697

Beneficiaries

—

Total drug cost

$1.5M

Distinct drugs

209

Brand share

17.3%

Top prescribed drugs

Gabapentin2,386 claims

Lisinopril1,701 claims

Simvastatin1,537 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

CROSS-REFERENCE

Related data on other Healthparse brands